Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02561897 · ClinicalTrials.gov registry record · Phase 4
EdoxabaN or Warfarin Therapy In Device Procedures in Patients With Non-Valvular Atrial Fibrillation
A Phase 4 study, sponsored by Electrophysiology Research Foundation.
- Terminated
- Registry status
- Phase 4
- Development phase
- 5
- Enrollment target
NCT02561897 is a Phase 4 study that was terminated before completion, run by Electrophysiology Research Foundation. The registered enrollment target is 5 participants.
The verdict
NCT02561897, a Phase 4 study, was terminated before completion, sponsored by Electrophysiology Research Foundation.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 5 participants
- Enrollment target
Study Summary
This is a prospective randomized comparative evaluation of Edoxaban and Warfarin for safety and efficacy in perioperative use in patients with non-valvular atrial fibrillation (AF) undergoing clinically indicated implantation or replacement of cardiovascular implantable electrical devices.The primary objective is to compare the rates of local and systemic bleeding in subjects randomized to Edoxaban compared to subjects randomized to continuous warfarin in within 30 days of cardiac rhythm device implant with concomitant non-valvular AF.
Interventions
- DRUG Warfarin
- DRUG Edoxaban
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2015-12 |
| Est. Completion | 2017-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02561897
The ClinicalTrials.gov registry entry for NCT02561897 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Electrophysiology Research Foundation, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Warfarin is the first listed.
NCT02561897 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02561897 about?
NCT02561897 is a clinical study titled "EdoxabaN or Warfarin Therapy In Device Procedures in Patients With Non-Valvular Atrial Fibrillation". This is a prospective randomized comparative evaluation of Edoxaban and Warfarin for safety and efficacy in perioperative use in patients with non-valvular atrial fibrillation (AF) undergoing clinically indicated implantation or replacement of cardiovascular implantable electrical devices.The primar...
What is the current status of trial NCT02561897?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 5 participants. The study started on 2015-12. Estimated completion is 2017-12.
What interventions are being tested in trial NCT02561897?
The interventions under investigation include: Warfarin (DRUG), Edoxaban (DRUG).
Who is sponsoring clinical trial NCT02561897?
This trial is sponsored by Electrophysiology Research Foundation, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.